Supplementary Table 2. Hazard ratio and 95% confidence interval for CVD according to non-HDL-C levels (excluded fatal CVD cases in the first 3 years).

	No. of events	Person-years	Model 1	Model 2	Model 3
Total CVD
Non-HDL-C (mg/dL)
＜110	29	61,433	1.27 (0.79-2.05)	1.44 (0.89-2.33)	1.56 (0.96-2.54)
110-＜130	34	79,230	1.02 (0.65-1.61)	1.08 (0.69-1.71)	1.12 (0.71-1.77)
130-＜150	41	89,698	Reference	Reference	Reference
150-＜170	55	70,670	1.49 (0.99-2.23)	1.41 (0.94-2.11)	1.38 (0.92-2.06)
≥ 170	85	84,637	2.02 (1.39-2.93)	1.81 (1.24-2.63)	1.72 (1.18-2.51)
Myocardial Infarction
Non-HDL-C (mg/dL)
＜110	2	61,433	0.37 (0.08-1.68)	0.46 (0.10-2.10)	0.54 (0.12-2.49)
110-＜130	4	79,230	0.50 (0.16-1.59)	0.55 (0.17-1.77)	0.60 (0.19-1.91)
130-＜150	10	89,698	Reference	Reference	Reference
150-＜170	20	70,670	2.20 (1.03-4.69)	2.01 (0.94-4.31)	1.94 (0.91-4.15)
≥ 170	29	84,637	2.73 (1.33-5.60)	2.30 (1.16-4.73)	2.09 (1.02-4.31)
1-SD increase			1.60 (1.38-1.86)	1.39 (1.20-1.61)	1.31 (1.12-1.53)
Hemorrhagic stroke
Non-HDL-C (mg/dL)
＜110	13	61,433	2.24 (0.98-5.14)	2.39 (1.03-5.52)	2.37 (1.02-5.51)
110-＜130	16	79,230	1.92 (0.87-4.24)	1.99 (0.90-4.40)	1.98 (0.90-4.38)
130-＜150	10	89,698	Reference	Reference	Reference
150-＜170	18	70,670	2.03 (0.94-4.41)	1.96 (0.91-4.25)	1.97 (0.91-4.28)
≥ 170	18	84,637	1.79 (0.83-3.89)	1.66 (0.77-3.62)	1.71 (0.78-3.73)
Ischemic stroke
Non-HDL-C (mg/dL)
＜110	14	61,433	1.25 (0.63-2.46)	1.37 (0.69-2.72)	1.54 (0.77-3.07)
110-＜130	14	79,230	0.83 (0.42-1.63)	0.87 (0.44-1.71)	0.91 (0.46-1.80)
130-＜150	21	89,698	Reference	Reference	Reference
150-＜170	15	70,670	0.78 (0.40-1.52)	0.75 (0.39-1.46)	0.73 (0.38-1.41)
≥ 170	38	84,637	1.76 (1.03-3.00)	1.61 (0.94-2.75)	1.50 (0.87-2.56)

Model 1: adjusted for age and sex

Model 2: further adjusted for smoking, BMI, hypertension, and diabetes

Model 3: further adjusted for HDL-C